Public–private partnerships to revitalize psychiatric drug discovery

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.9, Iss.1, 2014-01, pp. : 1-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

National Cooperative Drug Discovery Groups (NCDDGs): A Successful Model for Public Private Partnerships in Cancer Drug Discovery

By Hallock Yali Cragg Gordon

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 41, Iss. 1, 2003-12 ,pp. : 78-91

Informa Healthcare

Access to resources Recommend Favorite

Psychiatric Drug Discovery and Development

By Maubach Karen

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 9, 2003-09 ,pp. : 1571-1575

Informa Healthcare

Access to resources Recommend Favorite

Uzbekistan Drug Airlift: a Quantitative Analysis of Public/private Collaboration

By Wertheimer Albert Santella Thomas Arroyave Veronica

Pharmacy World and Science, Vol. 27, Iss. 4, 2005-08 ,pp. : 344-350

Springer Publishing Company

Access to resources Recommend Favorite

Prospects for neurodegenerative and psychiatric disorder drug discovery

By Williams Michael Enna S J

Expert Opinion on Drug Discovery, Vol. 6, Iss. 5, 2011-05 ,pp. : 457-463

Informa Healthcare

Access to resources Recommend Favorite

Leveraging Public Private Partnerships to Innovate under Challenging Budget Times

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 3, 2014-02 ,pp. : 326-329

Bentham Science Publishers

Access to resources Recommend Favorite